Skip to main content
. 2013 Apr 26;8(4):e62451. doi: 10.1371/journal.pone.0062451

Figure 1. The expression of SPARC & SPARC7 according to breast cancer subtype; basal (n−153), HER2 (n = 67), luminal-A (n = 342), luminal-B (n = 386).

Figure 1

A) SPARC expression was higher in luminal-A tumors compared to basal (p = 8.31E−27), HER2 (p = 9.42E−13) and luminal-B (p = 9.07E−14). Compared to basal, SPARC expression was higher in HER2 (p = 1.13E−05) and luminal-B (p = 6.77E−08). No difference in SPARC expression was observed between luminal-B and HER2 (p = 4.39E−01). B) SPARC7 expression was higher in luminal-A tumors compared to basal (p = 2.29E−21), HER2 (p = 1.57E−06) and luminal-B (p = 1.23E−08). Compared to basal, SPARC expression was higher in HER2 (p = 2.86E−06) and luminal-B (p = 1.34E−06). No difference in SPARC expression was observed between luminal-B and HER2 (p = 8.12E−01).